Lantern company information, Employees & Contact Information

Lantern Pharma to Present AI-Driven Oncology Pipeline at ThinkEquity Conference citybuzz -

New Lantern's AI-enabled additions aimed at streamlining mammo and PET workflows Radiology Business

Green Lantern Dark #7 Preview: Will Lanterns Save New England? Bleeding Cool News

New Lantern Expands AI Radiology Platform with Mammography and PET/CT Viewers Business Wire

What are AI’s effects on how we learn? Kentucky Lantern

Lantern Pharma Unveils Groundbreaking AI-Powered Module to Predict Activity and Efficacy of Combination Regimens in Clinical Cancer Treatment Yahoo Finance

New Lantern launches mammography, PET/CT viewer modes AuntMinnie

Lantern Pharma Reports Second Quarter 2025 Financial Results and Business Updates BioSpace

Dallas Biotech Launches Open-Access AI Tool Targeting One of Brain Drug Discovery’s Toughest Hurdles Dallas Innovates

94% Accurate AI Platform: Hoth Therapeutics Taps Revolutionary Blood-Brain Barrier Prediction Technology Stock Titan

IBN Announces Latest Episode of The BioMedWire Podcast GlobeNewswire

$23M Propels Startup’s Mission to Automate 90% of Radiology Tasks Using ‘AI Radiology Resident’ eWeek

Lantern Pharma (NASDAQ: LTRN) CEO Panna Sharma and New Board Member Dr. Lee Schalop Discuss How AI Can Reshape CNS Oncology Drug Development The Globe and Mail

Lantern Pharma Announces Public Release of Transformative, Advanced AI Module for Blood-Brain Barrier Permeability Prediction, predictBBB.ai™ Yahoo Finance

Aztec Group and Lantern Form a Strategic Alliance to Elevate Fund Data Access and Client Experience in Private Markets Business Wire

Kentucky lawmakers hope to continue the conversation about AI policies Kentucky Lantern

Green Lantern Brings Back A Character From Animated Series (Spoilers) Bleeding Cool News

Lantern Pharma Secures EU Patent Allowance for LP-284, Bolstering Global IP Position for AI-Developed Cancer Therapy Business Wire

Lantern Pharma Reports Complete Response in Heavily Pre-Treated Lymphoma Patient with LP-284 in Phase 1 Clinical Trial Business Wire

New Lantern Launches AI Radiology Resident, Raises $19M Series A Business Wire

Lantern Pharma Reports First Quarter 2025 Financial Results and Business Updates BioSpace

Introducing the Sailing Lantern The AI Journal

Lantern Advances Drug Candidate LP-184 with IND Clearance for Phase 1b/2 Clinical Trial in Triple Negative Breast Cancer (TNBC) Business Wire

Lantern Pharma Announces PCT Patent Application Publication for Innovative, High Performing, Machine Learning Model for Predicting Blood Brain Barrier Permeability of Drug-Candidates Business Wire

Lantern Pharma's AI-Driven Cancer Drug LP-184 Shows Promising Results in Phase 1a Trial citybuzz -

Lantern Pharma (NASDAQ: LTRN) Appoints Dr. Lee T. Schalop to Board to Bolster AI-Driven Precision Oncology The Globe and Mail

Lantern Pharma Unveils Innovative AI-Powered Module to Improve the Precision, Cost and Timelines of Antibody-Drug Conjugate (ADC) Development for Cancer Yahoo Finance

Lantern Pharma Secures FDA Clearance for Planned Phase 1b/2 Trial of LP-184 in Biomarker-Defined, Treatment-Resistant NSCLC Patients with High Unmet Clinical Need Business Wire

Lantern Pharma’s (NASDAQ: LTRN) AI-Powered Platform Delivers Promising and Durable Results in Lung Cancer Trial The Globe and Mail

Lantern Pharma Inc. (LTRN) Enhances RADR® AI Platform to Accelerate Development of Antibody-Drug Conjugates (ADCs) for Targeted Cancer Therapies Yahoo Finance

New Lantern: AI-Based Radiology Resident Company Raises $19 Million (Series A) Pulse 2.0

Benchmark invests $19M in New Lantern, a smarter way for radiologists to use AI TechCrunch

New Lantern Raises $19 Million in Series A The SaaS News

Lantern Pharma Inc. (LTRN): AI-Driven Cancer Drug Development Yahoo Finance

KY lawmakers wrap up their first examination of artificial intelligence, say it won’t be the last Kentucky Lantern

Lantern AI Quiz Builder Reveals Key Insights to Boost Shopify Store Revenue Newsfile

Lantern Pharma launches AI module to predict cancer treatment combos Investing.com

10 Years Later, 1 of DC's Greatest Heroes From TV Is Back and Finally Canon Screen Rant

Lantern Pharma (NASDAQ: LTRN) Subsidiary Starlight Therapeutics Cleared by FDA to Begin GBM Combination Trial The Globe and Mail

Lantern says AI-powered platform can find new ADC targets and payloads FirstWord Pharma

Beloved Green Lantern Character Brought Back to Life in DC All-In SuperHeroHype

Lantern Pharma (NASDAQ: LTRN) Reports Q2 Results with Clinical Trial, AI Platform Advancements The Globe and Mail

Startup aiming to automate 90% of imaging workflows, creating an ‘AI radiology resident,’ raises $23M Radiology Business

College students ‘cautiously curious’ about AI, despite mixed messages from schools, employers Kentucky Lantern

Lantern Pharma (NASDAQ: LTRN) Releases Latest AI Breakthrough for CNS Drug Development with predictBBB.ai The Globe and Mail

Why Lantern Pharma (NASDAQ: LTRN) Is ‘One to Watch’ The Globe and Mail

Revolutionizing Brain Diagnostics with Light and AI Neuroscience News

Lantern Pharma (NASDAQ: LTRN) Unveils AI Tool to Predict Blood-Brain Barrier Permeability with 94% Accuracy The Globe and Mail

Lantern Pharma (NASDAQ: LTRN) Launches AI Tool to Predict Efficacy of Cancer Drug Combinations The Globe and Mail

Celebrate the Lantern Festival with AI in Hangzhou news.cgtn.com

Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Second Fast Track Designation from FDA for Treatment of Triple Negative Breast Cancer (TNBC) Business Wire

New Lantern Launches AI Radiology Resident, Raises $19M Series A AI Insider

Radiology startup, Lantern, secures $19M to revolutionise AI tools in healthcare Digital Watch Observatory

Green Lantern #18 Preview: Oa's Insurance Rates Skyrocket Bleeding Cool News

Enjoy Lantern Festival traditional dessert with AI news.cgtn.com

New Lantern Emerges From Stealth with AI Radiology Resident and $19M Funding StartupHub.ai

Lantern Pharma advances AI-driven drug development with patent By Investing.com Investing.com UK

New Lantern Raises $19M in Series A Funding FinSMEs

Lantern Pharma's AI quest for $100M cancer drugs drugdiscoverytrends.com

How Lantern Pharma’s AI Is Changing the Game D Magazine

Busting the Brain's Firewall: How Lantern Pharma's Algorithms Can Predict a Drug's Ability to Reach the Brain Dallas Innovates

Oregon and Lantern collaborate to develop drug candidate for various cancer indications PharmaTimes

How AI is transforming drug discovery The Pharmaceutical Journal

Inside Lantern Pharma's Strategic AI Alliance with Code Ocean drugdiscoverytrends.com

Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 – A Potent Inhibitor of Cancer Metabolism Business Wire

Meet Lantern: A Microsoft-focused Consultancy, Poised to be a Digital Pioneer in the Era of AI PR Newswire

This High Schooler Invented an A.I.-Powered Trap That Zaps Invasive Lanternflies smithsonianmag.com

Lantern Pharma Leverages AI Platform, RADR®, to Develop Breakthrough Antibody Drug Conjugates (ADCs) in Collaboration with Bielefeld University BioSpace

Lantern Pharma Announces Positive Clinical Update from Ongoing Phase 2 HARMONIC™ Clinical Trial for Never Smokers with Advanced NSCLC, Including an 86% Clinical Benefit Rate in the Initial Patient Cohort Business Wire

Microsoft partners combine to form AI-oriented consultancy firm Lantern Mugglehead Magazine

High School Student Invents an A.I. Powered Trap That Zaps Invasive Lanternflies Good News Network

Lantern appoints inaugural CTO The Drawdown

Lantern Pharma and Actuate Therapeutics Announce Research & Development Collaboration Leveraging Lantern's Artificial Intelligence Platform PR Newswire

AI Generated Jack-o-Lantern Pattern Missing Eyes, Nose, Mouth hard-drive.net

James Gunn Clarifies Lanterns Credit, "Pukes" on Superman AI Trailer Bleeding Cool News

Green Lantern Lore Changes Forever with 1 Animated Character's Comics Debut Screen Rant

Lantern Pharma Announces Formation of Starlight Therapeutics to Advance Transformative Therapies for CNS (Central Nervous System) and Brain Cancers Business Wire

Dallas' Lantern Pharma Hits Major Milestone on its AI Platform to Advance its Oncology Drug Research and Development Dallas Innovates

Being AI seals conditional buyout of Spectrum Consulting Reseller News

Green Lantern’s Razer and Aya is love done right cliqueclack.com

Iron spirit: Ai Weiwei's Yorkshire Sculpture Park takeover – in pictures The Guardian